Home » Topics » Regulatory

Regulatory
RSS

FDA approval of new indication for Genentech's Activase

June 21, 1996

Mitsubishi Chem.'s Novastan receives Japanese approval for new indication

June 21, 1996

Vesnarinone treatment recommendations

June 21, 1996

Astra's Pulmicort approaches FDA approval

June 21, 1996

FDA approval of novel Claritin formulation sought

June 21, 1996

5-HT1A agonist for cognition disorders disclosed

June 21, 1996

AmBisome line extension receives Danish approval

June 21, 1996

FDA approves abbreviated treatment regimen for Vantin

June 21, 1996

Positive phase III results for new Solarase formulation

June 21, 1996

Vivus and Astra sign Muse licensing agreement

June 14, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Aug. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Aug. 19, 2025.
Subtyping beats a path toward precision medicine in Alzheimer’s
BioWorld MedTech
Subtyping is what made precision medicine in cancer a reality. And for successful drug discovery in all its stages, finding subtypes in Alzheimer’s disease is all...
Marvel Biotechnology’s MB-204 as therapeutic agent for Alzheimer’s disease
BioWorld Science
Phosphorylation of the protein Tau is a key post-translational feature in tauopathies like Alzheimer’s disease (AD), which leads to microtubule dysfunction and...
CSL to shave off 3,000 jobs, Seqirus vaccine unit
BioWorld
CSL Ltd.’s stock tumbled 16.88% on the news that it plans to cut 3,000 jobs and to hive off its Seqirus vaccine unit in a cost-cutting measure to save more than...